Patents by Inventor Jeffrey Askanazi

Jeffrey Askanazi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5578645
    Abstract: Methods and compositions for treating acute or chronic pain in a mammal comprising administering a therapeutically effective amount of an analgesic solution comprising at least one branched chain amino acid selected from the group consisting of leucine, isoleucine, and valine, or administering a therapeutically effective amount of an analgesic solution comprising an analgesic agent selected from the group consisting of an opioid, an agonistic-antagonistic agent, and an anti-inflammatory agent, and at least one branched chain amino acid selected from the group consisting of leucine, isoleucine, and valine. A method and composition for treating addiction to narcotic drugs comprises administering a therapeutically effective amount of a solution comprising methadone and at least one branched chain amino acid selected from the group consisting of leucine, isoleucine, and valine.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 26, 1996
    Assignee: Aminotek Sciences, Inc.
    Inventors: Jeffrey Askanazi, David P. Katz, Tuula Manner
  • Patent number: 5294642
    Abstract: A method for improving ventilation during sleep and treating sleep-related ventilation abnormalities. To this end, the present invention provides a method of using branched-chain amino acids as an effective therapy for sleep apnea. The branched-chain amino acid composition can be administered either parenterally or enterally, and can be administered alone or in combination with other nutrients. The branched-chain amino acid composition of the present invention functions as a ventilatory stimulator during sleep and does not result in any adverse effects either to the patient or to the sleep patterns of the patient. Preferably, the branched-chain amino acids comprise 60 to 85% of an amino acid solution that is administered to the patient.
    Type: Grant
    Filed: September 14, 1990
    Date of Patent: March 15, 1994
    Assignee: Clintec Nutrition Co.
    Inventors: Jeffrey Askanazi, Susan Trimbo
  • Patent number: 5278190
    Abstract: A method for improving the quality of sleep in a chronic renal failure patient is provided. To this end, the present invention provides a method of using branched-chain amino acids as an effective therapy for improving the quality of sleep. The branched-chain amino acid composition can be administered either parenterally or enterally, and can be administered alone or in combination with other nutrients. The composition can be administered during dialysis, intradialytic.
    Type: Grant
    Filed: April 9, 1992
    Date of Patent: January 11, 1994
    Assignee: Clintec Nutrition Co.
    Inventors: Jeffrey Askanazi, Susan Trimbo
  • Patent number: 5256669
    Abstract: Methods and compositions for treating acute or chronic pain in a mammal comprising administering a therapeutically effective amount of an analgesic solution comprising at least one branched chain amino acid selected from the group consisting of leucine, isoleucine, and valine, or administering a therapeutically effective amount of an analgesic solution comprising an analgesic agent selected from the group consisting of an opioid, an agonistic-antagonistic agent, and an anti-inflammatory agent, and at least one branched chain amino acid selected from the group consisting of leucine, isoleucine, and valine. A method and composition for treating addiction to narcotic drugs comprises administering a therapeutically effective amount of a solution comprising methadone and at least one branched chain amino acid selected from the group consisting of leucine, isoleucine, and valine.
    Type: Grant
    Filed: August 7, 1992
    Date of Patent: October 26, 1993
    Assignee: Aminotek Sciences, Inc.
    Inventors: Jeffrey Askanazi, David P. Katz, Tuula Manner
  • Patent number: 5140045
    Abstract: A method for improving ventilation during sleep and treating sleep-related ventilation abnormalities in an infant. To this end, the present invention provides a method of using branched-chain amino acids as an effective therapy for apnea of prematurity. The branched-chain amino acid composition can be administered either parenterally or enterally, and can be administered alone or in combination with other nutrients.
    Type: Grant
    Filed: February 15, 1991
    Date of Patent: August 18, 1992
    Assignee: Clintec Nutrition Co.
    Inventors: Jeffrey Askanazi, Susan Trimbo
  • Patent number: 5134130
    Abstract: A composition for the treatment of patients having Acquired Immune Deficiency Syndrome comprising approximately 2 to 7 percent by weight soybean oil and approximately 1 to 2 percent by weight egg phosphatide and a method for the parenteral administration of this composition is disclosed.
    Type: Grant
    Filed: August 21, 1991
    Date of Patent: July 28, 1992
    Assignee: Abbott Laboratories
    Inventors: Howard L. Shaw, Jeffrey Askanazi, William D. Leathem
  • Patent number: 5064810
    Abstract: A method for reducing respiratory muscle fatigue comprising the steps of administering a composition that includes branched chain amino acids. The composition can be administered either enterally or parenterally.
    Type: Grant
    Filed: September 14, 1990
    Date of Patent: November 12, 1991
    Inventors: Jeffrey Askanazi, Susan Trimbo
  • Patent number: 5017616
    Abstract: A method for improving ventilation during sleep and treating sleep-related ventilation abnormalities. To this end, the present invention provides a method of using branched-chain amino acids as an effective therapy for sleep apnea. The branched-chain amino acid composition can be administered either parenterally or enterally, and can be administered alone or in combination with other nutrients. The branched-chain amino acid composition of the present invention functions as a ventilatory stimulator during sleep and does not result in any adverse effects either to the patient or to the sleep patterns of the patient. Preferably, the branched-chain amino acids comprise 60 to 85% of an amino acid solution that is administered to the patient.
    Type: Grant
    Filed: November 30, 1989
    Date of Patent: May 21, 1991
    Inventor: Jeffrey Askanazi
  • Patent number: 5006559
    Abstract: This invention is a method of influencing voluntary food intake of patients receiving parenteral infusions, by adding branched-chain amino acids to the infusion solution. The branched-chain amino acid solution prevents total parenteral suppression of appetite and increases oral voluntary food intake. The branched-chain amino acid solution lowers the risk of regurgitation and aspiration in patients for uhm preoperative nutritional support and is an essential part of therapy.
    Type: Grant
    Filed: March 27, 1989
    Date of Patent: April 9, 1991
    Assignee: Clintec Nutrition Co.
    Inventors: Jeffrey Askanazi, Karen Gil